医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

InnoCare to Present at the Morgan Stanley 2020 Virtual Asia Pacific Conference & ZGC Forum

2020年09月17日 PM05:51
このエントリーをはてなブックマークに追加


 

BEIJING

InnoCare Pharmaceuticals (HKEX: 09969), a clinical stage biopharmaceutical company committed to discovering, developing, and commercializing innovative medicines for the treatment of cancer and autoimmune diseases, announced today that the company will present at the upcoming Morgan Stanley 2020 Virtual Asia Pacific Conference and ZGC Forum.

InnoCare CFO, Mr. Shaojing Tong, will join the China Biotech Panel of the Morgan Stanley conference to discuss and share the insights of China’s booming biotech industry on Thursday, September 24, 2020 China time.

Meanwhile, InnoCare will exhibit innovative medicine at the ZGC forum from September 17-20 in Beijing. Dr. Renbin Zhao, Executive Director of Biology and Clinical Development Strategy of InnoCare will present on the latest development of BTK inhibitor Orelabrutinib on the afternoon of Thursday, September 17, 2020, China time.

Founded in 2007, the ZGC forum has been held for years with the mission to promote communication, exchange, and cooperation in the field of science and technology worldwide.

About InnoCare Pharma

InnoCare Pharmaceuticals is a clinical stage biopharmaceutical company committed to discovering, developing, and commercializing first-in-class and/or best-in-class drugs for the treatment of cancer and autoimmune diseases. We strategically focus on lymphoma, solid tumors, and autoimmune disease with high unmet medical needs in China and worldwide. InnoCare has branches in Beijing, Nanjing, Shanghai, Guangzhou, New Jersey, and Boston.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200917005364/en/

CONTACT

Media

Chunhua Lu

86-10-66609879

chunhua.lu@innocarepharma.com

Investor Relations

86-10-66609999

ir@innocarepharma.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • エクセンシア、2022年第1四半期財務業績を2022年5月25日に報告
  • Anterra Capital:疫情和食品价格通胀激发了投资者对于加快食品和农业部门转型的兴趣
  • サーモの調査で、今年のASCOに参加するがん専門医が最も関心を寄せているのは肺がん・乳がんの新研究であることが判明
  • デンタル・モニタリングが包括的で生涯を通じた患者体験のための仮想診療プラットフォームを発表
  • Dental Monitoring推出虚拟诊疗平台,提供全方位的终身患者体验